Is Teritolumab covered by medical insurance? Will medical insurance reimburse this drug?

Teritusumab (teclistamab) is a monoclonal antibody drug developed by Genohe. It is mainly used to treat hematological malignancies such as multiple myeloma. The drug is already on the market in China, but it is not yet included in medical insurance. Therefore, patients need to bear the higher cost of the drug.

Although teritusumab is already on the market in China, due to its high price, it has not yet been included in the national medical insurance directory. This means that patients need to pay the full cost of the drug at the time of purchase and cannot reduce their financial burden through medical insurance reimbursement. Specific medical insurance policies may differ in different regions. It is recommended that patients consult the local hospital pharmacy when seeking medical treatment to find out whether there are special medical insurance reimbursement policies or clinical trial funding plans.

The price of Teritusumab’s generic drug is relatively high, especially when purchased overseas. A box of 153mg/1.7ml sells for about 50,000 yuan. This puts a heavy financial burden on many patients. Since there is no medical insurance reimbursement, many patients may consider other more economical purchase channels, or choose generic drugs to reduce cost pressure.

Patients can purchase teritusumab through different channels, usually including domestic drug stores, hospital pharmacies, and overseas drug suppliers. Since this drug has not yet been included in medical insurance, patients should pay special attention to price differences and legal purchasing channels when purchasing. For patients with limited budget, you can consider purchasing drugs overseas, such as purchasing from some overseas drug websites or professional international pharmacies, although this may require additional time and expense.

Although teritusumab is currently not included in the medical insurance, with the advancement of treatment technology and the popularization of drugs, the drug may be included in the medical insurance list in the future. The inclusion in medical insurance usually takes into account many factors such as the clinical effect of the drug, the needs of the patient, and the economics of the drug. If the drug can prove its clinical efficacy and long-term therapeutic effect, it may have a greater chance of entering the scope of medical insurance reimbursement in the next few years.

Reference materials:https://www.tecvayli.com/